Several analysts have recently updated their ratings and price targets for AstraZeneca (NASDAQ: AZN):1/27/2026 – AstraZeneca is now covered by analysts at Citigroup Inc.. 1/21/2026 – AstraZeneca had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings. 1/17/2026 – AstraZeneca was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating. 12/3/2025 – AstraZeneca had its “buy” rating reaffirmed by analysts at Guggenheim. Read MoreReceive News & Ratings for AstraZeneca PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca PLC and related companies with MarketBeat.com's FREE daily email newsletter.